Peer Exchange

August 10, 2017 – 
John B. Buse, MD, PhD, discusses the efficacy and safety findings from the EMPA-REG OUTCOME trial with empagliflozin in patients with type 2 diabetes mellitus.
Formulary Decisions and GLP-1/Insulin Combinations
August 08, 2017 – 
Louis S. Christos, RPh, outlines some of the potential benefits associated with glucagon-like peptide-1 (GLP-1) receptor agonist/insulin fixed-ratio combinations.
Cardiovascular Considerations in Antidiabetic Therapies
August 08, 2017 – 
Louis S. Christos, RPh, provides insight regarding the recent cardiovascular outcomes data with antidiabetes medications.
The Politics of Healthcare Reform
August 07, 2017 – 
Panelists Joseph Alvarnas, MD; Elizabeth Carpenter; Robert Carlson, MD; and John Fox, MD, predict possible outcomes for the future of healthcare reform.
Navigating Eligibility and Access Issues When Diagnosed
August 07, 2017 – 
Leonard Lichtenfeld, MD, identifies the issues behind coverage eligibility and access to oncology care.
A Historic View on CV Outcomes in Diabetes
August 04, 2017 – 
John B. Buse, MD, PhD, offers a historic perspective on the cardiovascular outcomes trials in type 2 diabetes mellitus, and the first trial to show benefit.
Shared Decision-Making in Diabetes
August 04, 2017 – 
John B. Buse, MD, PhD, provides insight on his shared decision-making process in type 2 diabetes mellitus and the most important factors to consider.
Appropriate Access: Payer Perspective on Newer Insulins
August 03, 2017 – 
Louis S. Christos, RPh, offers a payer perspective on determining appropriate access for ultraŚlong acting insulin therapies.
Evidence With UltraŚLong Acting Insulins
August 03, 2017 – 
Louis S. Christos, RPh, discusses the benefits associated with ultraŚlong acting insulin therapies and provides his perspective on the available evidence supporting their use.
The Balancing Act of Cost vs Access to Care
July 31, 2017 – 
Panelists John Fox, MD; Elizabeth Carpenter; John Fox, MD; and Robert Carlson, MD, provide insight on the intricate balance between the cost of, and access to, oncology care.
Copyright AJMC 2006-2017 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
Welcome to the new and improved, the premier managed markets network. Tell us about yourself so that we can serve you better.
Sign Up

Sign In

Not a member? Sign up now!